# Adding Urea to the Final Dialysis Fluid

> **NCT06366230** · PHASE1,PHASE2 · RECRUITING · sponsor: **University of California, San Francisco** · enrollment: 20 (estimated)

## Conditions studied

- Dysequilibrium Syndrome
- ESRD
- Hyperkalemia
- Metabolic Acidosis

## Interventions

- **DRUG:** Urea in the dialysate

## Key facts

- **NCT ID:** NCT06366230
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-16
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-06-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06366230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06366230, "Adding Urea to the Final Dialysis Fluid". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT06366230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*